Ping An Biomedical Co., Ltd.
corporate_fare Company Profile
Ping An Biomedical Co., Ltd. (NASDAQ:PASW) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 16 items for PASW at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-30, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 10/10, with 9 rated 8 or above. Recent SEC coverage for PASW spans 6-K, F-3, F-1, 20-F.
Recent high-impact activity:
- Ping An Shareholders Approve 40x Authorized Share Increase and Price-Triggered Further Consolidations
- Ping An Biomedical Files $300M Shelf Days After 1-for-40 Reverse Split
- Ping An Biomedical Seeks Vote to Lift Authorized Capital to US$12.5M and Pre-Approve Further Reverse Splits
- Ping An Biomedical Sets 1-for-40 Reverse Split Effective October 23
- 1-for-40 Reverse Split Set for October 23 as Nasdaq Delisting Risk Looms
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 370,293 shares in PASW as of the October 15, 2026 settlement, a 24.2% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 30, 2026, 62.7% of PASW volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for PASW, detected from its recent SEC filings.
Universal Shelf Registered · Practical Raise Capped by Tiny Float
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
PASW files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.